Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-470
Closed -$215K 175
2023
Q4
$215K Hold
470
0.15% 139
2023
Q3
$229K Buy
+470
New +$221K 0.17% 127
2021
Q1
Sell
-1,774
Closed -$728K 170
2020
Q4
$728K Buy
1,774
+84
+5% +$34.9K 0.56% 67
2020
Q3
$699K Sell
1,690
-2,028
-55% -$816K 0.87% 49
2020
Q2
$1.44M Buy
+3,718
New +$1.39M 1.64% 22
2018
Q4
Sell
-2,204
Closed -$746K 132
2018
Q3
$746K Buy
+2,204
New +$716K 0.44% 73
2016
Q3
Sell
-7,013
Closed -$1.26M 109
2016
Q2
$1.26M Buy
7,013
+615
+10% +$109K 1.3% 28
2016
Q1
$1.17M Buy
+6,398
New +$1.11M 1.46% 27

Other funds holding HUM

WESPAC Advisors's HUM Position: Q1 2024 in Review

WESPAC Advisors sold out of Humana (HUM) in Q1 2024, closing a stake of 470 shares — an estimated $215K sold.

WESPAC Advisors first reported a position in HUM in Q1 2016 and held it in 8 quarters. The position peaked at $1.44M in Q2 2020. 1,030 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

  • WESPAC Advisors reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
  • WESPAC Advisors sold 470 Humana shares in Q1 2024, an estimated $215K.
  • WESPAC Advisors first reported a position in Humana in Q1 2016 and held it in 8 quarters.
  • WESPAC Advisors's Humana position peaked at $1.44M in Q2 2020.
  • 1,030 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on WESPAC Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.